Quality assessment of the genetic test for familial hypercholesterolemia in the Netherlands

Cholesterol

Volumn 2013, Issue , 2013, Pages

  Kindt, Iris ^a   Huijgen, Roeland ^b   Boekel, Marieke ^a   Van Der Gaag, Kristiaan J ^c   Defesche, Joep C ^b   Kastelein, John J P ^b   De Knijff, Peter ^c  

^a Foundation for the Identification of Persons with Inherited Hypercholesterolemia (StOEH)   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Forensic Laboratory for DNA Research   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; DNA; EZETIMIBE; GENOMIC DNA; LOW DENSITY LIPOPROTEIN RECEPTOR; ROSUVASTATIN; SIMVASTATIN;

ADULT; ANALYTICAL ERROR; APOB GENE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FALSE POSITIVE RESULT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; GENETIC SCREENING; GOLD STANDARD; HUMAN; LDLR GENE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; NETHERLANDS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; STANDARDIZATION;

EID: 84880914516     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2013/531658     Document Type: Article

References (30)

1. Beaudet A. L., Which way for genetic-test regulation? Leave test interpretation to specialists. Nature 2010 466 7308 816 817 2-s2.0-77955619710 10.1038/466816a
2. Chen B., Gagnon M., Shahangian S., Anderson N. L., Howerton D. A., Joe Boone D., Good laboratory practices for molecular genetic testing for heritable diseases and conditions. Morbidity and Mortality Weekly Report 2009 58 -6 1 29 2-s2.0-67449086899
3. Goldstein J. L., Hobbs H. H., Brown M. S., The Metabolic and Molecular Bases of Inherited Disease 2001 New York, NY, USA McGraw-Hill
4. Huijgen R., Vissers M. N., Defesche J. C., Lansberg P. J., Kastelein J. J. P., Hutten B. A., Familial hypercholesterolemia: current treatment and advances in management. Expert Review of Cardiovascular Therapy 2008 6 4 567 581 2-s2.0-43049161243 10.1586/14779072.6.4.567
5. Versmissen J., Oosterveer D. M., Yazdanpanah M., Defesche J. C., Basart D. C. G., Liem A. H., Heeringa J., Witteman J. C., Lansberg P. J., Kastelein J. J. P., Sijbrands E. J. G., Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008 337 a2423 2-s2.0-79959332777
6. Leigh S. E. A., Foster A. H., Whittall R. A., Hubbart C. S., Humphries S. E., Update and analysis of the university college London low density lipoprotein receptor familial hypercholesterolemia database. Annals of Human Genetics 2008 72 4 485 498 2-s2.0-44849108492 10.1111/j.1469-1809.2008.00436.x (Pubitemid 351850090)
7. van der Graaf A., Avis H. J., Kusters D. M., Vissers M. N., Hutten B. A., Defesche J. C., Huijgen R., Fouchier S. W., Wijburg F. A., Kastelein J. J. P., Wiegman A., Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children. Circulation 2011 123 11 1167 1173 2-s2.0-79953066017 10.1161/CIRCULATIONAHA.110.979450
8. Damgaard D., Larsen M. L., Nissen P. H., Jensen J. M., Jensen H. K., Soerensen V. R., Jensen L. G., Faergeman O., The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis 2005 180 1 155 160 2-s2.0-17044427538 10.1016/j.atherosclerosis.2004.12.001
9. van Aalst-Cohen E. S., Jansen A. C. M., Tanck M. W. T., Defesche J. C., Trip M. D., Lansberg P. J., Stalenhoef A. F. H., Kastelein J. J. P., Diagnosing familial hypercholesterolaemia: the relevance of genetic testing. European Heart Journal 2006 27 18 2240 2246 2-s2.0-33748787440 10.1093/eurheartj/ehl113 (Pubitemid 44412840)
10. Assouline L., Levy E., Feoli-Fonseca J. C., Godbout C., Lambert M., Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population. Pediatrics 1995 96 2 239 246 2-s2.0-0029146594
11. Campagna F., Martino F., Bifolco M., Montali A., Martino E., Morrone F., Antonini R., Cantafora A., Verna R., Arca M., Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening. Atherosclerosis 2008 196 1 356 364 2-s2.0-38049156050 10.1016/j.atherosclerosis.2006.11.015
12. Graham C. A., McIlhatton B. P., Kirk C. W., Beattie E. D., Lyttle K., Hart P., Neely R. D. G., Young I. S., Nicholls D. P., Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate. Atherosclerosis 2005 182 2 331 340 2-s2.0-24644511304 10.1016/j.atherosclerosis.2005.02.016 (Pubitemid 41267202)
13. Punzalan F. E. R., Sy R. G., Santos R. S., Cutiongco E. M., Gosiengfiao S., Fadriguilan E., George P., Laurie A., Low density lipoprotein-receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia. Journal of Atherosclerosis and Thrombosis 2005 12 5 276 283 2-s2.0-33644819514
14. Umans-Eckenhausen M. A. W., Defesche J. C., Sijbrands E. J. G., Scheerder R. L. J. M., Kastelein J. J. P., Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. The Lancet 2001 357 9251 165 168 2-s2.0-0035915685 10.1016/S0140-6736(00)03587-X (Pubitemid 32108086)
15. Huijgen R., Kindt I., Verhoeven S. B. J., Sijbrands E. J. G., Vissers M. N., Kastelein J. J. P., Hutten B. A., Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal. PLoS ONE 2010 5 2 2-s2.0-77950174523 10.1371/journal.pone.0009220 e9220
16. Huijgen R., Homsma S. J., Hutten B. A., Kindt I., Vissers M. N., Kastelein J. J., van Rijckevorsel J. L., Improved access to life insurance after genetic diagnosis of familial hypercholesterolaemia: cross-sectional postal questionnaire study. European Journal of Human Genetics 2012 20 7 722 728 2-s2.0-84856325151 10.1038/ejhg.2012.5
17. Homsma S. J. M., Huijgen R., Middeldorp S., Sijbrands E. J. G., Kastelein J. J. P., Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance. European Journal of Human Genetics 2008 16 1 14 17 2-s2.0-37249037439 10.1038/sj.ejhg.5201940 (Pubitemid 350269234)
18. Huijgen R., Kindt I., Fouchier S. W., Defesche J. C., Hutten B. A., Kastelein J. J. P., Vissers M. N., Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia. Human Mutation 2010 31 6 752 760 2-s2.0-77952684113 10.1002/humu.21258
19. Huijgen R., Kindt I., Defesche J. C., Kastelein J. J., Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29 365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants. European Heart Journal 2012 33 18 2325 2330
20. Cobbaert C., Boerma G. J. M., Lindemans J., Evaluation of the Cholestech L.D.X. desktop analyser for cholesterol, HDL-cholesterol, and triacylglycerols in heparinized venous blood. European Journal of Clinical Chemistry and Clinical Biochemistry 1994 32 5 391 394 2-s2.0-0028179710
21. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
22. Gotto A. M. Jr., Bierman E. L., Connor W. E., Recommendations for treatment of hyperlipidemia in adults. A joint statement of the nutritism committee and the Council on arteriosclerosis. Circulation 1984 69 5 2-s2.0-0021264276
23. den Dunnen J. T., Antonarakis S. E., Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Human Mutation 2000 15 1 7 12 (Pubitemid 30036162)
24. Lombardi M. P., Redeker E. J. W., Defesche J. C., Kamerling S. W. A., Trip M. D., Mannens M. M. A. M., Havekes L. M., Kastelein J. J. P., Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in the Netherlands. Clinical Genetics 2000 57 2 116 124 2-s2.0-0033996671 10.1034/j.1399-0004.2000.570205.x (Pubitemid 30116590)
25. Fouchier S. W., Kastelein J. J. P., Defesche J. C., Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Human Mutation 2005 26 6 550 556 2-s2.0-28844468394 10.1002/humu.20256 (Pubitemid 41780477)
26. Castillo S., Tejedor D., Mozas P., Reyes G., Civeira F., Alonso R., Ros E., Pocoví M., Mata P., The apolipoprotein B R3500Q gene mutation in Spanish subjects with a clinical diagnosis of familial hypercholesterolemia. Atherosclerosis 2002 165 1 127 135 2-s2.0-0036840683 10.1016/S0021-9150(02) 00190-9 (Pubitemid 35223174)
27. Fokkema I. F. A. C., Den Dunnen J. T., Taschner P. E. M., LOVD: easy creation of a locus-specific sequence variation database using an "LSDB-in-a-Box" approach. Human Mutation 2005 26 2 63 68 2-s2.0-22844452823 10.1002/humu.20201 (Pubitemid 41040673)
28. Kusters D. M., Huijgen R., Defesche J. C., Vissers M. N., Kindt I., Hutten B. A., Kastelein J. J. P., Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein b genes. Netherlands Heart Journal 2011 19 4 175 182 2-s2.0-79955402735 10.1007/s12471-011-0076-6
29. Huijgen R., Stork A. D. M., Defesche J. C., Peter J., Alonso R., Cuevas A., Kastelein J. J. P., Duran M., Stroes E. S. G., Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis. Clinical Genetics 2012 81 1 24 28 2-s2.0-83355173945 10.1111/j.1399-0004.2011.01793.x
30. Talmud P. J., Shah S., Whittall R., Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. The Lancet 2013 381 9874 1293 1301 10.1016/S0140-6736(12)62127-8